Nevro (NVRO) | Stock Overview & Key Data
Nevro Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $188.14 on December 21, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2024
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nevro
NVRO
|
224.09M Micro-cap | N/A | N/A | N/A | N/A | N/A | -56.06% | -92.38% | -94.65% | -89.12% | -76.92% | -76.92% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
| 97.63B Large-cap | -3.98% | -11.24% | -33.00% | -49.28% | -50.63% | -52.97% | -13.64% | 9.04% | 108.58% | 590.87% | 133.50% | |
|
Zimvie
ZIMV
|
535.72M | 0.05% | 0.58% | 1.23% | 112.89% | 103.32% | 36.91% | 131.59% | -57.04% | -57.04% | -57.04% | -57.04% |
|
MaxCyte
MXCT
|
92.07M Micro-cap | 0.87% | 11.54% | 43.21% | -22.15% | -25.16% | -49.09% | -77.10% | -93.41% | -93.41% | -93.41% | -93.41% |
|
Tactile Systems
TCMD
|
556.25M Small-cap | 4.40% | 15.92% | -3.44% | -7.28% | -3.80% | 167.38% | 7.74% | -48.14% | 133.66% | 133.66% | 133.66% |
Ownership & Short Interest
Calculate Your Nevro Investment Returns
Long-Term Investment Performance Analysis
Nevro stock price in Aug 2016 was $96.40, A $1,000.00 lump sum investment in Nevro made 8 years ago would be worth approximately $60.58 today, representing a negative return of -93.94%. This translates to an annualized return (CAGR) of -27.21%.
8 Years 9 Months Investment Scenario (Aug 2016 - Jun 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NVRO's 52-week high and low?
- In the last 52 weeks, Nevro reached a high of $13.84 (on April 9, 2024) and a low of $3.16 (on January 10, 2025).
- What is the market cap and P/E ratio for NVRO?
- Curious about Nevro's size and valuation? Its market capitalization stands at 224.09M. When it comes to valuation, the P/E ratio (trailing twelve months) is 144.40, and the forward P/E (looking ahead) is -2.26.
- Does NVRO pay dividends? If so, what's the yield?
- As for dividends, Nevro isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nevro's main competitors or similar companies to consider before investing?
When looking at Nevro, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Boston Scientific
BSX97.63B Healthcare Medical Devices -52.97% -13.64% Zimvie
ZIMV535.72M Healthcare Medical Devices 36.91% 131.59% MaxCyte
MXCT92.07M Healthcare Medical Devices -49.09% -77.10% Tactile Systems
TCMD556.25M Healthcare Medical Devices 167.38% 7.74% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nevro Corp.? (e.g., ROE, Debt/Equity)
- To get a sense of Nevro's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -43.29%, the Debt to Equity ratio from the most recent quarter is 108.86, and its Gross Profit Margin stands at 62.45%.
- What is the recent revenue and earnings growth for NVRO?
- Looking at Nevro's growth, its revenue over the trailing twelve months (TTM) was $409M. Compared to the same quarter last year (YoY), quarterly revenue grew by -9.10%, and quarterly earnings saw a YoY growth of -9.15%.
- How much of NVRO stock is held by insiders and institutions?
- Wondering who owns Nevro stock? Company insiders (like executives and directors) hold about 2.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 110.59%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.